Controversial EU Study On Pharma Innovation & Access Sees The Light Of Day
Executive Summary
Members of the European Parliament committee charged with leading the negotiations on the review of the EU pharmaceutical legislation have been presented with a study backing cuts in data protection and wider joint procurement of medicines outside emergency situations.